Holen Sie sich die Stockscreener-App
17.42
3.38%
-0.61
Schlusskurs vom Vortag:
$18.03
Offen:
$18.04
24-Stunden-Volumen:
17.33M
Relative Volume:
0.70
Marktkapitalisierung:
$9.32B
Einnahmen:
$1.41B
Nettoeinkommen (Verlust:
$-91.57M
KGV:
-108.88
EPS:
-0.16
Netto-Cashflow:
$308.77M
1W Leistung:
-6.70%
1M Leistung:
+22.25%
6M Leistung:
+37.60%
1J Leistung:
+22.42%
1-Tages-Spanne:
$17.23
$18.09
1-Wochen-Bereich:
$17.23
$19.84
52-Wochen-Spanne:
$9.38
$19.84
Uipath Inc Stock (PATH) Company Profile
Firmenname
Uipath Inc
Sektor
Branche
Telefon
(844) 432-0455
Adresse
ONE VANDERBILT AVENUE, NEW YORK
Vergleichen Sie PATH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PATH
Uipath Inc
|
17.42 | 9.64B | 1.41B | -91.57M | 308.77M | -0.16 |
|
MSFT
Microsoft Corporation
|
478.53 | 3.59T | 293.81B | 104.91B | 78.02B | 14.06 |
|
ORCL
Oracle Corp
|
189.97 | 566.88B | 61.02B | 15.57B | -13.18B | 5.3215 |
|
PLTR
Palantir Technologies Inc
|
183.57 | 446.99B | 3.90B | 1.10B | 1.79B | 0.4275 |
|
CRWD
Crowdstrike Holdings Inc
|
504.78 | 130.50B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
452.95 | 90.95B | 7.05B | 1.34B | 1.35B | 8.0204 |
Uipath Inc Stock (PATH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-02 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-09-05 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-09-05 | Fortgesetzt | DA Davidson | Neutral |
| 2025-03-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-12 | Eingeleitet | UBS | Sell |
| 2024-06-03 | Herabstufung | Macquarie | Outperform → Neutral |
| 2024-05-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-05-30 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-05-30 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-30 | Herabstufung | Truist | Buy → Hold |
| 2024-05-30 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-04-08 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-03-14 | Bestätigt | Needham | Buy |
| 2024-02-21 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-01-02 | Eingeleitet | William Blair | Outperform |
| 2023-06-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-04-21 | Eingeleitet | DA Davidson | Neutral |
| 2023-03-16 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-11-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-10-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-09-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-01-25 | Hochstufung | Macquarie | Neutral → Outperform |
| 2022-01-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-09 | Hochstufung | Berenberg | Hold → Buy |
| 2021-12-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-09-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-12 | Eingeleitet | Summit Insights | Sell |
| 2021-05-17 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-05-17 | Eingeleitet | Barclays | Equal Weight |
| 2021-05-17 | Eingeleitet | BofA Securities | Buy |
| 2021-05-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-05-17 | Eingeleitet | Cowen | Outperform |
| 2021-05-17 | Eingeleitet | DA Davidson | Buy |
| 2021-05-17 | Eingeleitet | Evercore ISI | In-line |
| 2021-05-17 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-17 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2021-05-17 | Eingeleitet | Macquarie | Neutral |
| 2021-05-17 | Eingeleitet | Mizuho | Buy |
| 2021-05-17 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-17 | Eingeleitet | Needham | Buy |
| 2021-05-17 | Eingeleitet | Oppenheimer | Perform |
| 2021-05-17 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-05-17 | Eingeleitet | Truist | Buy |
| 2021-05-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-05-17 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-05-13 | Eingeleitet | Berenberg | Hold |
Alle ansehen
Uipath Inc Aktie (PATH) Neueste Nachrichten
Hudson Bay Capital Management LP Takes $102.56 Million Position in UiPath, Inc. $PATH - MarketBeat
Why UiPath’s Q3 results prompted analysts to recalibrate without upgrading - MSN
Why UiPath’s Q3 Results Prompted Analysts to Recalibrate Without Upgrading - Insider Monkey
UiPath (NYSE:PATH) Trading Down 3.4%Time to Sell? - MarketBeat
Analysts Raise UiPath Price Targets Post-Earnings - marketscreener.com
Watch Analysts Raise UiPath Price Targets Post-Earnings - Bloomberg.com
RBC turns more constructive on UiPath (PATH), raises PT following investor meetings - MSN
RBC Turns More Constructive on UiPath (PATH), Raises PT Following Investor Meetings - Finviz
UiPath, Inc. $PATH Shares Bought by TFG Asset Management GP Ltd - MarketBeat
UiPath Inc reports record growth amidst challenges - MSN
UiPath, Inc. $PATH Shares Acquired by Ieq Capital LLC - MarketBeat
UiPath Market Movement: Are Investors Ready to Act? - StocksToTrade
10 Best Agentic AI Stocks to Buy Now - Insider Monkey
Insider Sell: Daniel Dines Sells 45,000 Shares of UiPath Inc (PA - GuruFocus
UiPath (NYSE:PATH) Shares Down 3.6% on Insider Selling - MarketBeat
Better artificial intelligence stock: BigBear.ai vs. UiPath - MSN
UiPath Stock Jumps After Q3 Earnings: Here's Why - Sahm
Investors are piling into Palantir, but this AI competitor might outperform it in 2026 - MSN
Should Investors Buy UiPath Stock Before 2026? - The Motley Fool
Bank of Nova Scotia Purchases 320,700 Shares of UiPath, Inc. $PATH - MarketBeat
2 Artificial Intelligence Stocks That Could Help Make You a Fortune in 2026 - Finviz
UiPath (NYSE:PATH) Shares Down 1.6% Following Insider Selling - MarketBeat
RBC Capital Maintains UiPath (PATH) Sector Perform Recommendation - Nasdaq
Insider Selling: UiPath (NYSE:PATH) CEO Sells 45,000 Shares of Stock - MarketBeat
Uipath Insider Sold Shares Worth $837,482, According to a Recent SEC Filing - marketscreener.com
UiPath Integrates with Talkdesk to Streamline Customer Experience - CMSWire
Uipath Seeks M&A - marketscreener.com
RBC Capital raises UiPath stock price target to $19 on stabilizing trends - Investing.com Nigeria
RBC Capital raises UiPath stock price target to $19 on stabilizing trends By Investing.com - Investing.com South Africa
UiPath Business Trends Stabilizing as Automation Demand Grows, RBC Says - marketscreener.com
UiPath and Talkdesk join forces to transform customer experience journeys - Directors Club News -
UiPath (PATH) Price Target Raised by RBC Capital to $19 | PATH S - GuruFocus
UiPath (NYSE:PATH) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - MarketBeat
UiPath, Inc. $PATH Shares Sold by Sirios Capital Management L P - MarketBeat
RBC Raises Price Target on UiPath to $19 From $16, Keeps Sector Perform Rating - marketscreener.com
UiPath price stallsForecast today10-12-2025 - Economies.com
Amundi Grows Stock Position in UiPath, Inc. $PATH - MarketBeat
AGS Health(R) Earns Consecutive UiPath AI25 Award for Breakthroughs in Healthcare Denial Management - Livingston Daily
5 Revealing Analyst Questions From UiPath’s Q3 Earnings Call - Markets Financial Content
UiPath surges on earnings: Should investors chase the momentum? - MSN
UiPath (NYSE:PATH) Shares Down 1.7% After Insider Selling - MarketBeat
Uipath Insider Sold Shares Worth $861,071, According to a Recent SEC Filing - marketscreener.com
UiPath (PATH) Is Up 36.6% After First GAAP Profit And Strong Q4 Outlook Has The Bull Case Changed? - Yahoo Finance
Morgan Stanley Raises UiPath (PATH) Price Target to $19.00 | PAT - GuruFocus
UiPath Surges on Earnings: Should Investors Chase the Momentum? - MarketBeat
UiPath, Talkdesk Agree on Model Context Protocol-Based Agentic Integration - marketscreener.com
Better Artificial Intelligence Stock: BigBear.ai vs. UiPath - Finviz
UiPath price target raised to $19 from $15 at Morgan Stanley - TipRanks
Natixis Makes New Investment in UiPath, Inc. $PATH - MarketBeat
Decoding UiPath Inc (PATH): A Strategic SWOT Insight - GuruFocus
UiPath (NYSE:PATH) Insider Brad Brubaker Sells 27,580 Shares of Stock - MarketBeat
Finanzdaten der Uipath Inc-Aktie (PATH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.40%
1.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):